Definitive Contract 75F40120C00105
Award Date
8/17/20
Potential Completion Date
8/16/25
Potential Value
$8.5M
Federal Agency
Food and Drug Administration
Awardee
Pointcross, Inc.
Ultimate Awardee
Not listed
NAICS Category
541511 - Custom Computer Programming Services
PSC Category
D318 - It And Telecom- Integrated Hardware/Software/Services Solutions, Predominantly Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $1,424,274.00 Firm Fixed Price Delivery Order contract to Pointcross, Inc., a for-profit organization, for CTP Risk Modeling and Simulation Tool Support Services. The contract does not have a set-aside designation. Pointcross, Inc. is providing software platform license maintenance, upgrades, and support services for the agency's Risk Modeling and Simulation Tool over two consecutive 5-year periods....
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to Pointcross, Inc., a for-profit corporation, for a Risk Modeling and Simulation Tool (RMST) software platform license maintenance, upgrades, and support services. The contract has a potential value of $719,217.00 and a completion date of August 16, 2020. The award was made on a sole-source basis as a follow-on to an existing contract, with no set-aside designation. Pointcross also holds...
This is a delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Pointcross, Inc., a small business contractor. The contract is for operations and maintenance, as well as system enhancements, for the FDA's Risk Modeling and Simulation Tool. The contract has a ceiling value of $1,293,424.00 and a completion date of August 2, 2017. It is a firm fixed-price contract awarded non-competitively as a...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order contract worth $952,966.00 to Pointcross, Inc., a for-profit organization, to provide a Risk Modeling and Simulation Tool (RMST) for the Center for Tobacco Products. This non-set-aside contract is a follow-on to an existing agreement, allowing Pointcross to continue providing software platform license maintenance, upgrades, and support services for the FDA's toxicology...
This is a $973,595.78 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Pointcross, Inc., a for-profit organization based in Foster City, California. The contract is for the operation and maintenance of the FDA's National Integrated Monitoring System (NIMS), including production support and training services. The contract has no set-aside designation and was awarded non-competitively as a follow-on to an existing contract. Pointcross also holds a Multiple Award...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Simulations Plus Inc., a prime contractor that specializes in drug discovery and development simulation and modeling software. The $130,000 contract is for the extension and validation of Simulations Plus' GastroPlus ocular compartmental absorption and transit model. There is no set-aside designation for this contract. Simulations Plus has received over $5 million in...
This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $16,899 firm fixed price purchase order to Promodel Corporation for three ProModel licenses and five Process Simulator licenses. The non-competitive solicitation sought the proprietary simulation software licenses to support ongoing research protocols at NIH, indicating the licenses would allow continuation of science by using the vendor's specific software....
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a leading contract research organization specializing in predictive toxicology and ADME (absorption, distribution, metabolism, and excretion) research. The $18,024.00 firm fixed-price purchase order contract is for the testing of two compounds against key ADME and DMPK (drug metabolism and...
The Department of Health and Human Services' Food and Drug Administration awarded a $43,243.20 firm fixed price purchase order to Certara USA Inc. for SEND EXPLORER licenses. The place of performance is Silver Spring, Maryland. The one-year contract runs from September 12, 2023 through September 14, 2024. Certara USA Inc. will provide the FDA with software licenses to support the agency's regulatory science and public health protection missions. No subcontractors or set asides were identified....